Skip to main content
Top
Published in: Rheumatology International 2/2012

01-02-2012 | Original Article

Melatonin attenuates clock gene Cryptochrome1, which may aggravates mouse anti-type II collagen antibody-induced arthritis

Authors: Jihye Bang, Hyuk Won Chang, Hae-Ra Jung, Chul-Hyun Cho, Ji-An Hur, Sang-Il Lee, Tae Hyun Choi, Sang-Hyon Kim, Eunyoung Ha

Published in: Rheumatology International | Issue 2/2012

Login to get access

Abstract

Very recently, the circadian rhythm was proved to play an important role in the pathogenesis of arthritis. The role of melatonin in the development and progress of rheumatoid arthritis has been implicated for decades. This study was aimed to investigate the effect of melatonin on the expression of circadian clock genes in mouse anti-type II collagen antibody-induced arthritis (CIA). Mice were divided into 3 groups: control, CIA, and CIA + melatonin treatment (MLT). Both mRNA and protein levels of circadian clock gene Cryptochrome1 (Cry1) were markedly decreased in CIA + MEL group compared with those in control and CIA groups. MLT increased paw thickness. Histologic and X-ray assessment also revealed increased infiltration of inflammatory cells, synovial hyperplasia, and the destruction of articular cartilage and bone by MLT. The concentrations of anti-type II collagen antibody in CIA + MEL group mice were significantly higher than those in control and CIA groups (P < 0.05). Serum concentrations of TNF-α (P < 0.005) and IL-6 (P < 0.05) in CIA + MLT group were also increased. Taken together, these results implicate that clock gene Cry1 may be involved in the aggravation of MLT-mediated arthritis in mice anti-type II collagen antibody-induced arthritis.
Literature
1.
go back to reference Cutolo M, Straub RH, Buttgereit F (2008) Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside. Ann Rheum Dis 67:905–908PubMedCrossRef Cutolo M, Straub RH, Buttgereit F (2008) Circadian rhythms of nocturnal hormones in rheumatoid arthritis: translation from bench to bedside. Ann Rheum Dis 67:905–908PubMedCrossRef
2.
go back to reference Forrest CM, Mackay GM, Stoy N, Stone TW, Darlington LG (2007) Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol 64:517–526PubMedCrossRef Forrest CM, Mackay GM, Stoy N, Stone TW, Darlington LG (2007) Inflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin. Br J Clin Pharmacol 64:517–526PubMedCrossRef
3.
go back to reference Cardinali DP, Garcia AP, Cano P, Esquifino AI (2004) Melatonin role in experimental arthritis. Curr Drug Targets Immune Endocr Metabol Disord 4:1–10PubMedCrossRef Cardinali DP, Garcia AP, Cano P, Esquifino AI (2004) Melatonin role in experimental arthritis. Curr Drug Targets Immune Endocr Metabol Disord 4:1–10PubMedCrossRef
4.
go back to reference Hashiramoto A, Yamane T, Tsumiyama K, Yoshida K, Komai K, Yamada H, Yamazaki F, Doi M, Okamura H, Shiozawa S (2010) Mammalian clock gene cryptochrome regulates arthritis via proinflammatory cytokine TNF-α. J Immunol 184:1560–1565PubMedCrossRef Hashiramoto A, Yamane T, Tsumiyama K, Yoshida K, Komai K, Yamada H, Yamazaki F, Doi M, Okamura H, Shiozawa S (2010) Mammalian clock gene cryptochrome regulates arthritis via proinflammatory cytokine TNF-α. J Immunol 184:1560–1565PubMedCrossRef
5.
go back to reference Kanbe K, Inoue K, Xiang C, Chen Q (2006) Identification of clock as a mechanosensitive gene by large-scale DNA microarray analysis: downregulation in osteoarthritic cartilage. Mod Rheumatol 16:131–136PubMedCrossRef Kanbe K, Inoue K, Xiang C, Chen Q (2006) Identification of clock as a mechanosensitive gene by large-scale DNA microarray analysis: downregulation in osteoarthritic cartilage. Mod Rheumatol 16:131–136PubMedCrossRef
6.
go back to reference Ha E, Choe BK, Jung KH, Yoon SH, Park HJ, Yim SV, Chung JH, Bae HS, Nam M, Baik HH, Hong SJ (2005) Positive relationship between melatonin receptor type 1B polymorphism and rheumatoid factor in rheumatoid arthritis patients in Korean population. J Pineal Res 39:201–205PubMedCrossRef Ha E, Choe BK, Jung KH, Yoon SH, Park HJ, Yim SV, Chung JH, Bae HS, Nam M, Baik HH, Hong SJ (2005) Positive relationship between melatonin receptor type 1B polymorphism and rheumatoid factor in rheumatoid arthritis patients in Korean population. J Pineal Res 39:201–205PubMedCrossRef
7.
go back to reference Maestroni GJ, Sulli A, Pizzorni C, Villaggio B, Cutolo M (2002) Melatonin in Rheumatoid arthritis synovial macrophages show melatonin receptors. Ann NY Acad Sci 966:271–275PubMedCrossRef Maestroni GJ, Sulli A, Pizzorni C, Villaggio B, Cutolo M (2002) Melatonin in Rheumatoid arthritis synovial macrophages show melatonin receptors. Ann NY Acad Sci 966:271–275PubMedCrossRef
8.
go back to reference Couto-Moraes R, Palermo-Neto J, Markus RP (2009) The immune-pineal axis stress as a modulator of pineal gland function. Ann NY acad Sci 1153:193–202PubMedCrossRef Couto-Moraes R, Palermo-Neto J, Markus RP (2009) The immune-pineal axis stress as a modulator of pineal gland function. Ann NY acad Sci 1153:193–202PubMedCrossRef
9.
go back to reference Cutolo M, Maestroni GJ, Otsa K, Aakre O, Villaggio B, Capellino S, Montagna P, Fazzuoli L, Veldi T, Peets T, Hertens E, Sulli A (2005) Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis 64:212–216PubMedCrossRef Cutolo M, Maestroni GJ, Otsa K, Aakre O, Villaggio B, Capellino S, Montagna P, Fazzuoli L, Veldi T, Peets T, Hertens E, Sulli A (2005) Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis 64:212–216PubMedCrossRef
10.
go back to reference Cernysiov V, Gerasimcik N, Mauricas M, Girkontaite I (2010) Regulation of T-cell-independent and T-cell-dependent antibody production by circadian rhythm and melatonin. International Immunol 22:25–34CrossRef Cernysiov V, Gerasimcik N, Mauricas M, Girkontaite I (2010) Regulation of T-cell-independent and T-cell-dependent antibody production by circadian rhythm and melatonin. International Immunol 22:25–34CrossRef
11.
go back to reference Galijasevic S, Abdulhamid I, Abu-Soud HM (2008) Melatonin is a potent inhibitor for myeloperoxidase. Biochem 47:2668–2677CrossRef Galijasevic S, Abdulhamid I, Abu-Soud HM (2008) Melatonin is a potent inhibitor for myeloperoxidase. Biochem 47:2668–2677CrossRef
12.
go back to reference Yilmaz S, Yilmaz E (2006) Effects of melatonin and Vitamin E on oxidative-antioxidative status in rats exposed to irradiation. Toxicol 222:1–7CrossRef Yilmaz S, Yilmaz E (2006) Effects of melatonin and Vitamin E on oxidative-antioxidative status in rats exposed to irradiation. Toxicol 222:1–7CrossRef
13.
go back to reference Fernandes PA, Bothorel B, Clesse D, Monteiro AW, Calgari C, Raison S, Simonneaux V, Markus RP (2009) Local corticosterone infusion enhances nocturnal pineal melatonin production in vivo. J Neuroendocrinol 21:90–97PubMedCrossRef Fernandes PA, Bothorel B, Clesse D, Monteiro AW, Calgari C, Raison S, Simonneaux V, Markus RP (2009) Local corticosterone infusion enhances nocturnal pineal melatonin production in vivo. J Neuroendocrinol 21:90–97PubMedCrossRef
14.
go back to reference Lardone PJ, Carrillo-Vico A, Molinero P, Rubio A, Guerrero JM (2009) A novel interplay between membrane and nuclear melatonin receptors in human lymphocytes: significance in IL-2 production. Cell Mol Life Sci 66:516–525PubMedCrossRef Lardone PJ, Carrillo-Vico A, Molinero P, Rubio A, Guerrero JM (2009) A novel interplay between membrane and nuclear melatonin receptors in human lymphocytes: significance in IL-2 production. Cell Mol Life Sci 66:516–525PubMedCrossRef
15.
go back to reference Senel K, Baykal T, Melikoglu MA, Erdal A, Karatay S, Karakoc A, Ugur M (2009) Serum melatonin levels in anlylosing spondilitis: correlation with disease activity. Rheumatol Int. doi:10.1007/s00296-009-1223-x Senel K, Baykal T, Melikoglu MA, Erdal A, Karatay S, Karakoc A, Ugur M (2009) Serum melatonin levels in anlylosing spondilitis: correlation with disease activity. Rheumatol Int. doi:10.​1007/​s00296-009-1223-x
16.
go back to reference Brittney JH, Russel RJ, Ahmad N (2010) Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res 48:9–19CrossRef Brittney JH, Russel RJ, Ahmad N (2010) Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res 48:9–19CrossRef
17.
go back to reference Westhoff G, Buttgereit F, Gromnica-Ihle E, Zink A (2008) Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis. Rheumatol 47:980–984CrossRef Westhoff G, Buttgereit F, Gromnica-Ihle E, Zink A (2008) Morning stiffness and its influence on early retirement in patients with recent onset rheumatoid arthritis. Rheumatol 47:980–984CrossRef
18.
go back to reference Jimenez-Caliani AJ, Jimenez-Jorge S, Molinero P, Guerrero JM, Fernandez-Santos JM, Martin-Lacave I, Osuna C (2005) Dual effect of melatonin as proinflammatory and antioxidant in collagen-induced arthritis in rats. J Pineal Res 38:93–99PubMedCrossRef Jimenez-Caliani AJ, Jimenez-Jorge S, Molinero P, Guerrero JM, Fernandez-Santos JM, Martin-Lacave I, Osuna C (2005) Dual effect of melatonin as proinflammatory and antioxidant in collagen-induced arthritis in rats. J Pineal Res 38:93–99PubMedCrossRef
Metadata
Title
Melatonin attenuates clock gene Cryptochrome1, which may aggravates mouse anti-type II collagen antibody-induced arthritis
Authors
Jihye Bang
Hyuk Won Chang
Hae-Ra Jung
Chul-Hyun Cho
Ji-An Hur
Sang-Il Lee
Tae Hyun Choi
Sang-Hyon Kim
Eunyoung Ha
Publication date
01-02-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 2/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1641-9

Other articles of this Issue 2/2012

Rheumatology International 2/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine